Lacson: Ex-PS-DBM OIC Lao violated anti-graft law with huge Pharmally contracts

Lacson: Ex-PS-DBM OIC Lao violated anti-graft law with huge Pharmally contracts

By Ernie Reyes

MANILA — Lloyd Christopher Lao, ex-OIC of the Department of Budget and
Management Procurement Service (PS-DBM), violated the Anti-Graft Law
by giving Pharmally Pharmaceuticals Corp. huge contracts way beyond
its Net Financial Contracting Capacity (NFCC), Sen. Panfilo M. Lacson
bared Thursday.

At the Senate Blue Ribbon hearing on irregularities involving the
procurement of medical supplies to deal with the Covid pandemic,
Lacson said Pharmally had net working capital of P599,450 and could
only be given a maximum contract of P5.994 million.

Yet, Pharmally bagged its first contract amounting to P13.86 million –
more than twice the maximum – and even got a second contract amounting
to P54 million, all within the same year, Lacson said, citing
documents so far obtained during the hearing.

“Bakit una pa lang na delivery, nasa P13 milyon agad mahigit? May
violation agad dito (Why is it that in its first delivery, it already
raked in more than P13 million? Here we can immediately see the
violation),” Lacson said.

“They have no financial capability pero pinapasok nila (Pharmally had
no financial capability but got these huge contracts),” he added.

He told Senate Blue Ribbon panel chairman Richard Gordon that he may
include in his preliminary committee report this “clear violation” of
the Anti-Graft Law, where the administrative requirement was not
followed.

Lacson pointed out that Lao exceeded his authority or did not follow
the provisions of the Procurement Law.

“Mag-agree kayo sa akin, in-exceed ni Lao ang kanyang authority o
hindi sinunod ang alituntunin sa Procurement Law, na times 10 lang ng
maximum sa net working capital (You will agree with me that Lao
exceeded his authority or did not follow the Procurement Law’s
provision on the net working capital),” he said.

Lacson noted the NFCC is part of the eligibility documents of bidders
under the Government Procurement Policy Board (GPPB) Resolution
16-2020.

Citing Pharmally’s Statement of Financial Position, Lacson noted
Pharmally in 2019 had net working capital of P599,450, and an NFCC
of P5,994,500.

“Dapat maximum na makuhang kontrata ng Pharmally, hindi lalampas ng
P5.9M (Pharmally should not have gotten a contract exceeding P5.9
million),” Lacson said.

Yet Pharmally, despite its lack of financial capacity, was awarded
some P11.11 billion in contracts from the government, Lacson said.

” Pharmally should not have been given a contract that is more than 10
times its net working capital. Yet it got hefty deliveries,” he said. (ai/mtvn)

Leave a Reply